SIM
COCH icon

Sandia Investment Management’s Envoy Medical COCH Stock Holding History

Sandia Investment Management’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-500,000
Closed -$5.21M – 179
2023
Q3 		$5.21M Hold
500,000
– – 1.42% 19
2023
Q2 		$5.12M Hold
500,000
– – 1.13% 25
2023
Q1 		$5.03M Buy
500,000
+439,412
+725% +$4.4M 0.92% 32
2022
Q4 		$607K Sell
60,588
-111
-0.2% -$1.1K 0.11% 111
2022
Q3 		$596K Hold
60,699
– – 0.09% 145
2022
Q2 		$595K Buy
60,699
+2,590
+4% +$25.4K 0.08% 166
2022
Q1 		$568K Buy
+58,109
New +$565K 0.08% 170

Other funds holding COCH

AMC
Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Sandia Investment Management's COCH Position: Q4 2023 in Review

Sandia Investment Management sold out of Envoy Medical (COCH) in Q4 2023, closing a stake of 500,000 shares — an estimated $5.21M sold.

Sandia Investment Management first reported a position in COCH in Q1 2022 and held it in 7 quarters. The position peaked at $5.21M in Q3 2023. 9 funds tracked by Wall St. Rank hold COCH as of Q4 2023.

  • Sandia Investment Management reported no remaining Envoy Medical position as of Q4 2023 after selling out during the quarter.
  • Sandia Investment Management sold 500,000 Envoy Medical shares in Q4 2023, an estimated $5.21M.
  • Sandia Investment Management first reported a position in Envoy Medical in Q1 2022 and held it in 7 quarters.
  • Sandia Investment Management's Envoy Medical position peaked at $5.21M in Q3 2023.
  • 9 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2023.

Based on Sandia Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.